ArticleCell reports. Medicine2023

Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancer.

Inês Gomes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.